Insulin therapy for older adults with diabetes

Geriatrics and Aging

Volumn 11, Issue 6, 2008, Pages 357-362

  Segal, Alissa R ^a,b   Munshi, Medha N ^b,c,d  

^a MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b JOSLIN DIABETES CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Diabetes; Geriatrics; Glycemic control; Insulin therapy; Older adults

Indexed keywords

EID: 49749106252     PISSN: 14888408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States. Atlanta (GA): US Department of Health and Human Services, The Centers; 2005.
2. Kahn SE, Haffner SM, Heise MA, et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 2006;355:2427-43.
3. Turner RC, Cull CA, Frighi V, et al. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 1999;281:2005-12.
4. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-86.
5. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-53.
6. ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-72.
7. Silliman RA, Bhatti S, Khan A, et al. The care of older persons with diabetes mellitus: families and primary care physicians. J Am Geriatr Soc 1996;44:1314-21.
8. Shorr RI, Ray WA, Daugherty JR, et al. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med 1997;157:1681-6.
9. Huang ES, Gorawara-Bhat R, Chin MH. Self-reported goals of older patients with type 2 diabetes mellitus. J Am Geriatr Soc 2005;53:306-11.
10. Huang ES, Shook M, Jin L, et al. The impact of patient preferences on the cost-effectiveness of intensive glucose control in older patients with new-onset diabetes. Diabetes Care 2006;29:259-64.
11. DeWitt DE, Hirsch IB. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review. JAMA 2003;289:2254-64.
12. Daugherty KK. Review of insulin therapy. J Pharm Pract 2004;17:10-9.
13. Hirsch IB. Insulin analogues. N Engl J Med 2005;352:174-83.
14. Sakharova OV, Inzucchi SE. Treatment of diabetes in the elderly. Addressing its complexities in this high-risk group. Postgrad Med 2005;118:19-26, 29.
15. Devries JH, Nattrass M, Pieber TR. Refining basal insulin therapy: what have we learned in the age of analogues? Diabetes Metab Res Rev 2007;23:441-54.
16. Soran H, Younis N. Insulin detemir: a new basal insulin analogue. Diabetes Obes Metab 2006;8:26-30.
17. Brown AF, Mangione CM, Saliba D, et al. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc 2003;51(5 Suppl):S265-80.
18. Wallsten SM, Sullivan RJ Jr, Hanlon JT, et al. Medication taking behaviors in the high- and low-functioning elderly: MacArthur field studies of successful aging. Ann Pharmacother 1995;29:359-64.
19. Suh DC, Kim CM, Choi IS, et al. Comorbid conditions and glycemic control in elderly patients with type 2 diabetes mellitus, 1988 to 1994 to 1999 to 2004. J Am Geriatr Soc 2008;56:484-92.
20. Munshi M, Grande L, Hayes M, et al. Cognitive dysfunction is associated with poor diabetes control in older adults. Diabetes Care 2006;29:1794-9.
21. Sinclair AJ, Girling AJ, Bayer AJ. Cognitive dysfunction in older subjects with diabetes mellitus: impact on diabetes self-management and use of care services. All Wales Research into Elderly (AWARE) Study. Diabetes Res Clin Pract 2000;50:203-12.
22. Sinclair AJ, Conroy SP, Bayer AJ. Impact of diabetes on physical function in older people. Diabetes Care 2008;31:233-5.
23. Vinks TH, de Koning FH, de Lange TM, et al. Identification of potential drug-related problems in the elderly: the role of the community pharmacist. Pharm World Sci 2006;28:33-8.
24. Zammitt NN, Frier BM. Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care 2005;28:2948-61.
25. Saudek CD, Hill Golden S. Feasibility and outcomes of insulin therapy in elderly patients with diabetes mellitus. Drugs Aging 1999;14:375-85.
26. Chelliah A, Burge MR. Hypoglycaemia in elderly patients with diabetes mellitus: causes and strategies for prevention. Drugs Aging 2004;21:511-30.
27. Davis SN. Insulin, oral hypoglycemic agents and the pharmacology of the endocrine pancreas. In: Brunton LL, ed. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 11th edition. New York: McGraw-Hill; 2006.
28. Standards of medical care in diabetes - 2008. Diabetes Care 2008;31 Suppl 1:S12-54.
29. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-12. Can J Diabet 2003;27 (suppl 2).
30. Canadian Diabetes Association. Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada.
31. Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2006;29:1963-72.
32. Mooradian AD, Bernbaum M, Albert SG. Narrative review: a rational approach to starting insulin therapy. Ann Intern Med 2006;145:125-34.
33. Rosenstock J. Management of type 2 diabetes mellitus in the elderly: special considerations. Drugs Aging 2001;18:31-44.
34. White JR Jr, Campbell RK, Hirsch IB. Novel insulins and strict glycemic control. Analogues approximate normal insulin secretory response. Postgrad Med 2003;113:30-6.
35. Leahy JL. Basal-prandial insulin therapy: scientific concept review and application. Am J Med Sci 2006;332:24-31.
36. McCall AL, Cox DJ, Crean J, et al. A novel analytical method for assessing glucose variability: using CGMS in type 1 diabetes mellitus. Diabetes Technol Ther 2006;8:644-53.
37. Tavris DR, Shoaibi A. The public health impact of the MiniMed Continuous Glucose Monitoring System (CGMS) - an assessment of the literature. Diabetes Technol Ther 2004;6:518-22.